Tapinarof Cream Looks Promising for Plaque Psoriasis – MPR
Positive results were announced from two phase 3 studies evaluating tapinarof cream (Dermavant Sciences) for plaque psoriasis.
Positive results were announced from two phase 3 studies evaluating tapinarof cream (Dermavant Sciences) for plaque psoriasis.
The PDUFA date refers to the deadline set by the US Food and Drug Administration for reviewing drug applications.
Dr Charles Raison, the Director of Clinical Research at the Usona Institute and Professor in the Department of Psychiatry at the University of Wisconsin–Madison, talks to…
Distribution will end on June 1, 2024.
Each Ingrezza Sprinkle capsule contains oral granules consisting of valbenazine, a vesicular monoamine transporter 2 inhibitor.
Dr Charles Raison, the Director of Clinical Research at the Usona Institute and Professor in the Department of Psychiatry at the University of Wisconsin–Madison, talks to…
Beqvez is a one-time AAV-based gene therapy designed to introduce in the transduced cells a functional copy of the FIX gene encoding a high-activity FIX…
MamaLift Plus is intended as an adjunct to clinician-managed outpatient care to provide neurobehavioral interventions to patients 22 years of age and older with mild…
Nogapendekin alfa inbackicept-pmin is an interleukin-15 receptor agonist.
The approval was based on data from the phase 3 VISIBLE 2 trial.
The double-blind, phase 3 study included 2 groups of patients, those who were not on positive airway pressure therapy and those who were.